BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6242693)

  • 1. [Clinical value of radioimmunological HPL findings in the long-term care of threatened abortion].
    Ruckhäberle KE; Bilek K; Viehweg B; Kühndel K; Colditz U; Bär G
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():43-9. PubMed ID: 6242693
    [No Abstract]   [Full Text] [Related]  

  • 2. Estradiol, estriol and human placental lactogen in serum in threatened abortion.
    Hertz JB; Larsen JF; Svenstrup B; Johnsen SG
    Acta Obstet Gynecol Scand; 1979; 58(4):365-70. PubMed ID: 525270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunological assessment of the placental lactogen concentration in threatened abortion].
    Szymanski W; Przylepa M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():57-63. PubMed ID: 6242695
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is there any evidence that the maternal HPL serum-concentration is of prognostic value in cases of threatened abortion? (author's transl)].
    Berle P; Behnke K
    Z Geburtshilfe Perinatol; 1977 Jun; 181(3):211-7. PubMed ID: 888497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of HPL radioimmunoassay in normal and pathologic early pregnancy].
    Hör G; Wallner H; Pabst HW; Domanowsky W
    Nucl Med (Stuttg); 1975 Jan; 13(4):371-8. PubMed ID: 1114050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood hormone levels in threatened abortion].
    Fedorova MV; Bespalova VA; Tereshchenko LI; Khokhlova ID
    Akush Ginekol (Mosk); 1984 Dec; (12):31-3. PubMed ID: 6241799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic significance of the placental lactogen and estriol content of the blood pregnant women].
    Lopatchenko OI
    Akush Ginekol (Mosk); 1981 May; (5):32-4. PubMed ID: 7294303
    [No Abstract]   [Full Text] [Related]  

  • 8. Placental lactogen levels in threatened abortion.
    Niven PA; Chard T
    Proc R Soc Med; 1973 Feb; 66(2):188. PubMed ID: 4714661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interactions between beta-mimetics and indices of feto-placental function].
    Forcucci-Zulli M; Moggian G; Pini PL
    Minerva Ginecol; 1985 Mar; 37(3):89-92. PubMed ID: 4022442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of radioimmunologic determination of placental lactogen hormone to the prognosis of spontaneous threatened abortion].
    Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):331-04. PubMed ID: 4681537
    [No Abstract]   [Full Text] [Related]  

  • 11. [Placental (HPL, HSAP, CAP) and fetal (estriol in urine and blood) parameters in high risk pregnancies].
    Battaglia GB; Morresi G; Coronella L; Messeri G; Valenza T
    Quad Sclavo Diagn; 1977 Dec; 13(4):434-48. PubMed ID: 351694
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. The role of serum human placental lactogen determination.
    Vorster CZ; Pannall PR; Slabber CF
    S Afr Med J; 1977 Feb; 51(6):165-6. PubMed ID: 841444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunologic evaluation of the concentration of placental lactogen in threatened abortions].
    Szymanski W; Przylepa M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():57-63. PubMed ID: 6211055
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioimmunologic determination of placental lactogenic hormone in threatened spontaneous abortion. Prognostic value compared with determination of chorionic gonadotrophic hormone (HCG)].
    Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(1):53-62. PubMed ID: 4807227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
    Kyank HR
    Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal supervision of threatened abortion. diagnosis and therapy (author's transl)].
    Knapstein P
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):970-2. PubMed ID: 6775195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation.
    Briët JW; Hoorn RK
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):7-14. PubMed ID: 7060818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentrations of total oestriol, non-conjugated oestriol, human placental lactogen and oxytocinase in the serum, and total oestrogens in the urine of pregnant women, following the administration of betamethasone (author's transl)].
    Knoll E; Kayser A; Wisser H
    J Clin Chem Clin Biochem; 1978 Nov; 16(11):621-4. PubMed ID: 731194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of high-risk pregnancies (author's transl)].
    Davi D; Vernotico V; Bottoni A; Vallini A; Candi L; Zanella B
    Quad Sclavo Diagn; 1978 Dec; 14(4):468-85. PubMed ID: 757621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.